The global antiinfective API market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth in this market is attributed to the increasing prevalence of infectious diseases and rising demand for anti-infective drugs. The respiratory infections API segment is expected to grow at a CAGR of 6.2% during the forecast period, owing to increasing incidence rates of respiratory tract infections and growing demand for antibiotics in emerging economies such as China and India. The skin infections API segment is expected to grow at a CAGR of 4.8%, owing to increasing incidence rates of skin infections and growing demand for antibiotics in emerging economies such as China and India.
-The global population is increasing, which will lead to an increase in the number of people who are susceptible to infection.
-There is a lack of new antibiotics being developed, which will lead to an increase in demand for existing drugs.
-There are many different types of infections that can be treated with antiinfectives, so there is a large market potential.
-Antiinfectives are often used as prophylaxis against infection and as treatment for chronic conditions such as HIV/AIDS and cancer, which leads to increased demand for these drugs.
Industry Growth Insights published a new data on “Antiinfective API Market”. The research report is titled “Antiinfective API Market research by Types (Respiratory Infections API, Skin Infections API, Other), By Applications (Oral Medicine, Injection), By Players/Companies ACS Dobfar, Sterile India, Nectar Lifesciences, Kopran, Qilu Pharmaceutial, Hangzhou Viwa, Daewoong Bio, Fresenius Kabi iPSUM, Sinopharm Weiqida Pharmaceutical, Virchow Healthcare, United Laboratories International Holdings, Dawnrays, CSPC Pharmaceutical, Orchid Pharma, Guangzhou Pi & Pi Biotech”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Antiinfective API Market Research Report
By Type
Respiratory Infections API, Skin Infections API, Other
By Application
Oral Medicine, Injection
By Companies
ACS Dobfar, Sterile India, Nectar Lifesciences, Kopran, Qilu Pharmaceutial, Hangzhou Viwa, Daewoong Bio, Fresenius Kabi iPSUM, Sinopharm Weiqida Pharmaceutical, Virchow Healthcare, United Laboratories International Holdings, Dawnrays, CSPC Pharmaceutical, Orchid Pharma, Guangzhou Pi & Pi Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Antiinfective API Market Report Segments:
The global Antiinfective API market is segmented on the basis of:
Types
Respiratory Infections API, Skin Infections API, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Medicine, Injection
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ACS Dobfar
- Sterile India
- Nectar Lifesciences
- Kopran
- Qilu Pharmaceutial
- Hangzhou Viwa
- Daewoong Bio
- Fresenius Kabi iPSUM
- Sinopharm Weiqida Pharmaceutical
- Virchow Healthcare
- United Laboratories International Holdings
- Dawnrays
- CSPC Pharmaceutical
- Orchid Pharma
- Guangzhou Pi & Pi Biotech
Highlights of The Antiinfective API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Respiratory Infections API
- Skin Infections API
- Other
- By Application:
- Oral Medicine
- Injection
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Antiinfective API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An antiinfective API refers to a set of APIs that allow developers to access and integrate various anti-microbial technologies into their applications. These APIs can help developers track the efficacy of antimicrobial treatments, optimize treatment regimens, and identify potential resistance patterns.
Some of the key players operating in the antiinfective api market are ACS Dobfar, Sterile India, Nectar Lifesciences, Kopran, Qilu Pharmaceutial, Hangzhou Viwa, Daewoong Bio, Fresenius Kabi iPSUM, Sinopharm Weiqida Pharmaceutical, Virchow Healthcare, United Laboratories International Holdings, Dawnrays, CSPC Pharmaceutical, Orchid Pharma, Guangzhou Pi & Pi Biotech.
The antiinfective api market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Antiinfective API Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Antiinfective API Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Antiinfective API Market - Supply Chain
4.5. Global Antiinfective API Market Forecast
4.5.1. Antiinfective API Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Antiinfective API Market Size (000 Units) and Y-o-Y Growth
4.5.3. Antiinfective API Market Absolute $ Opportunity
5. Global Antiinfective API Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Antiinfective API Market Size and Volume Forecast by Type
5.3.1. Respiratory Infections API
5.3.2. Skin Infections API
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Antiinfective API Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Antiinfective API Market Size and Volume Forecast by Application
6.3.1. Oral Medicine
6.3.2. Injection
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Antiinfective API Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Antiinfective API Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Antiinfective API Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Antiinfective API Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Antiinfective API Demand Share Forecast, 2019-2026
9. North America Antiinfective API Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Antiinfective API Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Antiinfective API Market Size and Volume Forecast by Application
9.4.1. Oral Medicine
9.4.2. Injection
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Antiinfective API Market Size and Volume Forecast by Type
9.7.1. Respiratory Infections API
9.7.2. Skin Infections API
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Antiinfective API Demand Share Forecast, 2019-2026
10. Latin America Antiinfective API Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Antiinfective API Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Antiinfective API Market Size and Volume Forecast by Application
10.4.1. Oral Medicine
10.4.2. Injection
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Antiinfective API Market Size and Volume Forecast by Type
10.7.1. Respiratory Infections API
10.7.2. Skin Infections API
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Antiinfective API Demand Share Forecast, 2019-2026
11. Europe Antiinfective API Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Antiinfective API Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Antiinfective API Market Size and Volume Forecast by Application
11.4.1. Oral Medicine
11.4.2. Injection
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Antiinfective API Market Size and Volume Forecast by Type
11.7.1. Respiratory Infections API
11.7.2. Skin Infections API
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Antiinfective API Demand Share, 2019-2026
12. Asia Pacific Antiinfective API Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Antiinfective API Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Antiinfective API Market Size and Volume Forecast by Application
12.4.1. Oral Medicine
12.4.2. Injection
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Antiinfective API Market Size and Volume Forecast by Type
12.7.1. Respiratory Infections API
12.7.2. Skin Infections API
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Antiinfective API Demand Share, 2019-2026
13. Middle East & Africa Antiinfective API Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Antiinfective API Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Antiinfective API Market Size and Volume Forecast by Application
13.4.1. Oral Medicine
13.4.2. Injection
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Antiinfective API Market Size and Volume Forecast by Type
13.7.1. Respiratory Infections API
13.7.2. Skin Infections API
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Antiinfective API Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Antiinfective API Market: Market Share Analysis
14.2. Antiinfective API Distributors and Customers
14.3. Antiinfective API Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ACS Dobfar
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sterile India
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Nectar Lifesciences
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Kopran
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Qilu Pharmaceutial
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hangzhou Viwa
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Daewoong Bio
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Fresenius Kabi iPSUM
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Sinopharm Weiqida Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Virchow Healthcare
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. United Laboratories International Holdings
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Dawnrays
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. CSPC Pharmaceutical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Orchid Pharma
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Guangzhou Pi & Pi Biotech
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
